Zenyth Therapeutics Overview

  • Founded
  • 1986

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Zenyth Therapeutics General Information


Manufacturer and developer of antibody-based therapies intended to serve in the areas of inflammation and cancer. The company's antibody, therapies and receptor alpha subunit enables its users in asthma and other respiratory diseases.

Contact Information

Formerly Known As
Amrad Corporation Limited
Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 576 Swan Street
  • Richmond, Victoria 3121
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zenyth Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zenyth Therapeutics‘s full profile, request access.

Request a free trial